The company Covalent Laboratories manufactures active pharmaceutical ingredients and bulk drugs in city of Hyderabad, India. In 2012, the organization added a brand new manufacturing plant and was in the process of getting regulatory approvals for its products from the U.S. Food and Drug Administration and the European Directorate of Quality of Medicines. The company is a brand new client with typical financial strength as well as the proposed financial assistance is long term in nature; a predicament is faced by the head of the bank's Corporate Banking Department. He has requested a credit analyst to study the fiscal performance of the company and to evaluate the financial viability of and identify the hazards in the proposition. Writers are affiliated with Indian Institute of Management Shillong.
This is just an excerpt. This case is about FINANCE & ACCOUNTING
PUBLICATION DATE: June 17, 2015 PRODUCT #: W15241-PDF-ENG
Related Case Solutions & Analyses:
Bon Star Hotel
Societe Generale (A): The Jerome Kerviel Affair
Giving Customers a Fair Hearing
Vanguard Group Inc.–1998
China Metal Recycling Holdings Limited: Scrap King Gets Scrapped
Activity Based Costing
Off-Balance Sheet Leases in the Restaurant Industry
M & A- Anheuser-Busch InBev
Back to School: Real Estate Development of Off-Campus Student Housing
Legendary Pictures & ABRY Partners
